Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
Submitted by
admin
on November 22, 2016 - 11:23am
Source:
Seeking Alpha
News Tags:
MannKind
Afrezza
diabetes
inhaled insulin
Headline:
MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
Do Not Allow Advertisers to Use My Personal information
